Literature DB >> 19005904

Circadian variability of cystatin C, creatinine, and glomerular filtration rate (GFR) in healthy men during normal sleep and after an acute shift of sleep.

Anders Larsson1, Torbjörn Akerstedt, Lars-Olof Hansson, John Axelsson.   

Abstract

The estimation of the glomerular filtration rate (GFR) is essential for the evaluation of patients with kidney disease and for the treatment of patients with medications that are eliminated by the kidneys. Plasma cystatin C has been shown in several studies to be superior to plasma creatinine for the estimation of GFR. However, there is limited information on the circadian variation of cystatin C and estimated GFR using cystatin C (eGFR(CystC)) or "The Modification of Diet in Renal Disease Study" (MDRD) (eGFR(MDRD)) equations. We studied the circadian variation of cystatin C and creatinine during night- and day-sleep conditions in seven healthy volunteers. Serum samples were collected every hour (48 samples per individual) to evaluate the effect of different sampling times on the test results. The median intra-individual coefficients of variations for the studied markers were 4.2% for creatinine, 4.7% for eGFR(MDRD), 5.5% for cystatin C, and 7.7% for eGFR(CystC). Neither cystatin C nor creatinine differed significantly between the night- and day-sleep conditions. Cystatin C differed significantly with time of day (p=.0003), but this was not the case for creatinine (p=.11). The circadian variation of cystatin C was minor. Small but significant increases in creatinine values and a decrease of eGFR(MDRD) were observed after food intake. Thus, cystatin C and creatinine sampling does not have to be restricted to specific times of the day.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19005904     DOI: 10.1080/07420520802553614

Source DB:  PubMed          Journal:  Chronobiol Int        ISSN: 0742-0528            Impact factor:   2.877


  6 in total

Review 1.  Changes in renal function in congestive heart failure.

Authors:  Guido Boerrigter; Berthold Hocher; Harald Lapp
Journal:  Curr Heart Fail Rep       Date:  2013-12

Review 2.  The global burden of chronic kidney disease: estimates, variability and pitfalls.

Authors:  Richard J Glassock; David G Warnock; Pierre Delanaye
Journal:  Nat Rev Nephrol       Date:  2016-12-12       Impact factor: 28.314

3.  Predictors of Post-discharge Mortality Among Patients Hospitalized for Acute Heart Failure.

Authors:  Ovidiu Chioncel; Sean P Collins; Stephen J Greene; Peter S Pang; Andrew P Ambrosy; Elena-Laura Antohi; Muthiah Vaduganathan; Javed Butler; Mihai Gheorghiade
Journal:  Card Fail Rev       Date:  2017-11

4.  Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposure.

Authors:  Sophie Jose; Lisa Hamzah; Lucy J Campbell; Teresa Hill; Martin Fisher; Clifford Leen; Richard Gilson; John Walsh; Mark Nelson; Phillip Hay; Margaret Johnson; David Chadwick; Dorothea Nitsch; Rachael Jones; Caroline A Sabin; Frank A Post
Journal:  J Infect Dis       Date:  2014-02-28       Impact factor: 5.226

5.  Development of a Competitive Cystatin C-Specific Bioassay Suitable for Repetitive Measurements.

Authors:  Tatjana Damm; Holger Spiegel; Stefan Barth; Rainer Fischer; Joerg Naehring
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

6.  Dose banding - Weighing up benefits, risks and therapeutic failure.

Authors:  Stephen Duffull
Journal:  Br J Clin Pharmacol       Date:  2022-03-24       Impact factor: 3.716

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.